The shareholding of CUPF Alianz Bulgaria in the capital of Sopharma AD
Sopharma AD received a a notification for disclosure of a shareholding under Art. 145 of the CUPF Allianz Bulgaria for acquiring shares from the capital of Sopharma AD, as a result of which the shareholding of CUPF Allianz Bulgaria in the capital of Sopharma AD exceeds the limit of 5% and reaches 5.09%.
The date of the registration of the transaction with the Central Depository is January 23, 2019.
Sales revenues for December 2018
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for December 2018 the Company recorded an increase of sales revenues of 26% compared to the same month of 2017, including 75% increase of domestic sales and a decrease of 1% of export sales.
In 2018 revenue from sales of goods decreased by 3% compared to the same period in 2017, incl. 3% increase in sales for the domestic market and 7% decrease in export sales.
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 28, 2018
Notification from Sopharma AD under Art. 19 of Regulation (EU) No 596/2014 of December 28, 2018
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 27, 2018
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of December 21, 2018
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 21, 2018
Notification from Sopharma AD under Art. 19 of Regulation (EU) No 596/2014 of December 21, 2018
Treasury shares
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on December 28, 2018 the Company bought 314 own shares representing 0.0002% of the share capital of the Company, at a total value of 1 105.28 BGN on the Bulgarian Stock Exchange, the average price per share was 3.52 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from February 23, 2018.
The total number of treasury shares after this transaction is 8 881 650, representing 6.59% of the share capital of the Company.